Improving access to quality medicines in East Africa: An independent perspective on the East African Community Medicines Regulatory Harmonization initiative

1. Ndomondo-Sigonda M, Mahlangu G, Agama-Anyetei M, Cooke E. A new approach to an old problem: Overview of the East African Community’s Medicines Regulatory Harmonization initiative. PLoS Med. 2020;17(8): e1003099. doi: 10.1371/journal.pmed.1003099

2. Sillo H, Ambali A, Azatyan S, Chamdimba C, Kaale E, Kabatende J, et al. Coming together to improve access to medicines: The genesis of the East African Community’s Medicines Regulatory Harmonization initiative. PLoS Med. 2020;17(8): e1003133. doi: 10.1371/journal.pmed.1003133

3. Mashingia JH, Ahonkhai V, Aineplan N, Ambali A, Angole A, Arik M, et al. Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned. PLoS Med. 2020;17(8): e1003134. doi: 10.1371/journal.pmed.1003134

4. Arik M, Bamenyekanye E, Fimbo A, Kabatende J, Kijo AS, Simai B, et al. Optimizing the East African Community’s Medicines Regulatory Harmonization initiative in 2020–2022: A Roadmap for the Future. PLoS Med. 2020;17(8): e1003129. doi: 10.1371/journal.pmed.1003129

5. Bren L. Frances Oldham Kelsey. FDA medical reviewer leaves her mark on history. FDA Consum. 2001;35(2):24–9. 11444245

6. Office of Surveillance and Epidemiology (OSE) mission statement. US Food & Drug Administration website. 2019. Available from: https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-surveillance-and-epidemiology-ose-divisions. [cited 2019 Dec 9].

7. Pharmacovigilance: Overview. European Medicines Agency website. 2019. Available from: https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview. [cited 2019 Dec 9].

8. Medicines approval system: Marketing authorisations for medicinal products within the EU. European Union Heads of Medicines Agencies website. 2019. Available from: https://www.hma.eu/medicinesapprovalsystem.html. [cited 2019 Sep 16].

9. CHMP: Working parties and other groups. European Medicines Agency website. 2019. Available from: https://www.ema.europa.eu/en/committees/working-parties-other-groups/chmp-working-parties-other-groups. [cited 2019 Sep 24].

10. European Medicines Agency (EMA) website. 2019. Available from: https://www.ema.europa.eu/en. [cited 2019 Aug 23].

11. Dansie LS, Odoch WD, Ardal C. Industrial perceptions of medicines regulatory harmonization in the East African Community. PLoS ONE. 2019;14(6):e0218617. doi: 10.1371/journal.pone.0218617 31216323

12. Foreign Corrupt Practices Act. US Department of Justice website. 2017. Available from: https://www.justice.gov/criminal-fraud/foreign-corrupt-practices-act. [cited 2019 Dec 9].

13. Sauer F. Pharmaceutical harmonisation in Europe and beyond. J Pharm Drug Devel. 2019;1(2).

14. Ukwu H. Global Regulatory Systems: A Strategic Primer for Biopharmaceutical Product Development and Registration. Boston, MA: CenterWatch; 2011.

15. Guidelines. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) website. 2019. Available from: https://www.ich.org/products/guidelines.html. [cited 2019 Aug 23].

16. Medicines. European Medicines Agency (EMA) website. 2019. Available from: https://www.ema.europa.eu/en/medicines/field_ema_web_categories%253Aname_field/Human/ema_group_types/ema_medicine. [cited 2019 Aug 23].

17. Council of Europe. European Pharmacopoeia (9th ed.). Strasbourg: Council of Europe; 2015.

18. United States Pharmacopeia and National Formulary (USP 42-NF 37). Rockville, MD: United States Pharmacopeial Convention; 2019.

19. World Health Organization. Good Practices of National Regulatory Authorities in Implementing the Collaborative Registration Procedures for Medical Products. Working Document QAS/18.774. WHO website. 2018. Available from: http://origin.who.int/medicines/areas/quality_safety/quality_assurance/02_08_2018_qas18_774_good_practices_of_NRAs_implementing_CRP_clean.pdf. [cited 2019 Sep 9].

20. Mota C, Barbosa J, Liberti L, Bonamici D, Grignolo A. Expedited regulatory pathways in established and emerging markets. DIA Global Forum website. 2018. Available from: https://globalforum.diaglobal.org/issue/september-2018/expedited-regulatory-pathways-in-established-and-emerging-markets/. [cited 2019 Aug 23].

21. Keyter A, Salek S, Banoo S, Walker S. The South African Medicines Control Council: Comparison of its registration process with Australia, Canada, Singapore, and Switzerland. Front Pharmacol. 2019;10 : 228. doi: 10.3389/fphar.2019.00228 30923501

22. McAuslane N, Bujar M, Liberti L. Understanding the Dynamics of China’s Medicine Regulatory Environment. Centre for Innovation in Regulatory Science R&D Briefing 56. 2015.

23. Medicrime. Council of Europe website. 2019. Available from: https://www.coe.int/en/web/medicrime. [cited 2019 Sep 9].

24. Ndomondo-Sigonda M, Miot J, Naidoo S, Ambal A, Dodoo A, Mkandawire H. The African Medicines Regulatory Harmonization initiative: Progress to date. Medical Res Arch. 2018;6(2).

25. Ndomondo-Sigonda M, Agama-Anyetei M, Mahlangu G, Mkandawire H. African Medicines Agency Establishment Treaty adopted by African Ministers of Health. DIA Global Forum website. 2018. Available from: https://globalforum.diaglobal.org/issue/july-2018/african-medicines-agency-establishment-treaty-adopted-by-african-ministers-of-health/. [cited 2019 May 30].